nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—Indapamide—Oxcarbazepine—epilepsy syndrome	0.219	1	CrCrCtD
Furosemide—CA4—epilepsy syndrome	0.124	0.6	CbGaD
Furosemide—ABCC2—epilepsy syndrome	0.0597	0.289	CbGaD
Furosemide—ALB—epilepsy syndrome	0.023	0.111	CbGaD
Furosemide—SLCO2A1—Phenobarbital—epilepsy syndrome	0.0215	0.0545	CbGbCtD
Furosemide—CA14—Lacosamide—epilepsy syndrome	0.017	0.0431	CbGbCtD
Furosemide—CA6—Lacosamide—epilepsy syndrome	0.0162	0.0409	CbGbCtD
Furosemide—CA5B—Lacosamide—epilepsy syndrome	0.0141	0.0356	CbGbCtD
Furosemide—CA9—Lacosamide—epilepsy syndrome	0.0121	0.0306	CbGbCtD
Furosemide—CA14—Acetazolamide—epilepsy syndrome	0.0117	0.0296	CbGbCtD
Furosemide—CA1—Lacosamide—epilepsy syndrome	0.0113	0.0286	CbGbCtD
Furosemide—CA6—Acetazolamide—epilepsy syndrome	0.0111	0.0281	CbGbCtD
Furosemide—CA5A—Acetazolamide—epilepsy syndrome	0.0111	0.0281	CbGbCtD
Furosemide—CA14—Zonisamide—epilepsy syndrome	0.0108	0.0274	CbGbCtD
Furosemide—CA4—Lacosamide—epilepsy syndrome	0.0106	0.0269	CbGbCtD
Furosemide—CA6—Zonisamide—epilepsy syndrome	0.0103	0.026	CbGbCtD
Furosemide—CA5A—Zonisamide—epilepsy syndrome	0.0103	0.026	CbGbCtD
Furosemide—CA2—Lacosamide—epilepsy syndrome	0.00977	0.0247	CbGbCtD
Furosemide—CA5B—Acetazolamide—epilepsy syndrome	0.00969	0.0245	CbGbCtD
Furosemide—CA7—Acetazolamide—epilepsy syndrome	0.00969	0.0245	CbGbCtD
Furosemide—CA5B—Zonisamide—epilepsy syndrome	0.00896	0.0227	CbGbCtD
Furosemide—CA7—Zonisamide—epilepsy syndrome	0.00896	0.0227	CbGbCtD
Furosemide—CA9—Acetazolamide—epilepsy syndrome	0.00831	0.0211	CbGbCtD
Furosemide—CA12—Acetazolamide—epilepsy syndrome	0.00831	0.0211	CbGbCtD
Furosemide—CA1—Acetazolamide—epilepsy syndrome	0.00778	0.0197	CbGbCtD
Furosemide—ABCC2—Levetiracetam—epilepsy syndrome	0.0077	0.0195	CbGbCtD
Furosemide—CA9—Zonisamide—epilepsy syndrome	0.00769	0.0195	CbGbCtD
Furosemide—CA12—Zonisamide—epilepsy syndrome	0.00769	0.0195	CbGbCtD
Furosemide—CA5A—Topiramate—epilepsy syndrome	0.00749	0.019	CbGbCtD
Furosemide—CA6—Topiramate—epilepsy syndrome	0.00749	0.019	CbGbCtD
Furosemide—CA4—Acetazolamide—epilepsy syndrome	0.00731	0.0185	CbGbCtD
Furosemide—CA1—Zonisamide—epilepsy syndrome	0.0072	0.0182	CbGbCtD
Furosemide—CA4—Zonisamide—epilepsy syndrome	0.00677	0.0171	CbGbCtD
Furosemide—CA2—Acetazolamide—epilepsy syndrome	0.00672	0.017	CbGbCtD
Furosemide—CA7—Topiramate—epilepsy syndrome	0.00653	0.0165	CbGbCtD
Furosemide—CA5B—Topiramate—epilepsy syndrome	0.00653	0.0165	CbGbCtD
Furosemide—CA2—Zonisamide—epilepsy syndrome	0.00622	0.0158	CbGbCtD
Furosemide—CA12—Topiramate—epilepsy syndrome	0.00561	0.0142	CbGbCtD
Furosemide—CA9—Topiramate—epilepsy syndrome	0.00561	0.0142	CbGbCtD
Furosemide—CA1—Topiramate—epilepsy syndrome	0.00524	0.0133	CbGbCtD
Furosemide—CA4—Topiramate—epilepsy syndrome	0.00493	0.0125	CbGbCtD
Furosemide—CA2—Topiramate—epilepsy syndrome	0.00453	0.0115	CbGbCtD
Furosemide—ABCC2—Carbamazepine—epilepsy syndrome	0.00442	0.0112	CbGbCtD
Furosemide—ALB—Oxcarbazepine—epilepsy syndrome	0.00439	0.0111	CbGbCtD
Furosemide—ABCC2—Phenytoin—epilepsy syndrome	0.00397	0.01	CbGbCtD
Furosemide—ALB—Fosphenytoin—epilepsy syndrome	0.00384	0.00971	CbGbCtD
Furosemide—ABCC2—Phenobarbital—epilepsy syndrome	0.00353	0.00895	CbGbCtD
Furosemide—ALB—Clonazepam—epilepsy syndrome	0.00347	0.00878	CbGbCtD
Furosemide—SLC22A5—Valproic Acid—epilepsy syndrome	0.00339	0.00859	CbGbCtD
Furosemide—ALB—Rufinamide—epilepsy syndrome	0.00283	0.00716	CbGbCtD
Furosemide—SLC22A8—Valproic Acid—epilepsy syndrome	0.00277	0.00703	CbGbCtD
Furosemide—SLC22A6—Acetazolamide—epilepsy syndrome	0.00259	0.00655	CbGbCtD
Furosemide—ALB—Phenytoin—epilepsy syndrome	0.00247	0.00626	CbGbCtD
Furosemide—ALB—Propofol—epilepsy syndrome	0.0023	0.00584	CbGbCtD
Furosemide—ALB—Diazepam—epilepsy syndrome	0.00209	0.00529	CbGbCtD
Furosemide—CA6—ear—epilepsy syndrome	0.00201	0.102	CbGeAlD
Furosemide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00193	0.00489	CbGbCtD
Furosemide—Bumetanide—SLC12A5—epilepsy syndrome	0.0011	0.419	CrCbGaD
Furosemide—SLC12A1—ganglion—epilepsy syndrome	0.000965	0.0488	CbGeAlD
Furosemide—Bumetanide—SLC12A2—epilepsy syndrome	0.000537	0.205	CrCbGaD
Furosemide—CA4—ganglion—epilepsy syndrome	0.000519	0.0263	CbGeAlD
Furosemide—CA14—telencephalon—epilepsy syndrome	0.000415	0.021	CbGeAlD
Furosemide—SLC12A1—forebrain—epilepsy syndrome	0.000405	0.0205	CbGeAlD
Furosemide—CA4—hindbrain—epilepsy syndrome	0.000394	0.0199	CbGeAlD
Furosemide—SLC12A1—telencephalon—epilepsy syndrome	0.000372	0.0188	CbGeAlD
Furosemide—CA7—midbrain—epilepsy syndrome	0.000357	0.0181	CbGeAlD
Furosemide—CA12—forebrain—epilepsy syndrome	0.000352	0.0178	CbGeAlD
Furosemide—Indapamide—CA4—epilepsy syndrome	0.000335	0.128	CrCbGaD
Furosemide—PGD—forebrain—epilepsy syndrome	0.000333	0.0168	CbGeAlD
Furosemide—CA2—hindbrain—epilepsy syndrome	0.000326	0.0165	CbGeAlD
Furosemide—CA14—medulla oblongata—epilepsy syndrome	0.000326	0.0165	CbGeAlD
Furosemide—CA12—telencephalon—epilepsy syndrome	0.000323	0.0164	CbGeAlD
Furosemide—PGD—telencephalon—epilepsy syndrome	0.000306	0.0155	CbGeAlD
Furosemide—CA6—head—epilepsy syndrome	0.0003	0.0152	CbGeAlD
Furosemide—CA14—midbrain—epilepsy syndrome	0.000298	0.0151	CbGeAlD
Furosemide—Bumetanide—SLCO1A2—epilepsy syndrome	0.000297	0.113	CrCbGaD
Furosemide—Bumetanide—CA4—epilepsy syndrome	0.000294	0.112	CrCbGaD
Furosemide—CA14—spinal cord—epilepsy syndrome	0.00029	0.0147	CbGeAlD
Furosemide—CA1—forebrain—epilepsy syndrome	0.000278	0.0141	CbGeAlD
Furosemide—CA7—cerebellum—epilepsy syndrome	0.000276	0.014	CbGeAlD
Furosemide—SLC12A1—spinal cord—epilepsy syndrome	0.000261	0.0132	CbGeAlD
Furosemide—CA1—telencephalon—epilepsy syndrome	0.000256	0.013	CbGeAlD
Furosemide—CA9—cerebellum—epilepsy syndrome	0.000243	0.0123	CbGeAlD
Furosemide—PGD—medulla oblongata—epilepsy syndrome	0.000241	0.0122	CbGeAlD
Furosemide—SLC12A1—head—epilepsy syndrome	0.000232	0.0117	CbGeAlD
Furosemide—CA14—cerebellum—epilepsy syndrome	0.00023	0.0116	CbGeAlD
Furosemide—CA4—brainstem—epilepsy syndrome	0.000226	0.0114	CbGeAlD
Furosemide—CA7—brain—epilepsy syndrome	0.000225	0.0114	CbGeAlD
Furosemide—PGD—midbrain—epilepsy syndrome	0.00022	0.0111	CbGeAlD
Furosemide—SLC12A1—nervous system—epilepsy syndrome	0.00022	0.0111	CbGeAlD
Furosemide—CA4—forebrain—epilepsy syndrome	0.000218	0.011	CbGeAlD
Furosemide—PGD—spinal cord—epilepsy syndrome	0.000214	0.0109	CbGeAlD
Furosemide—SLCO2A1—head—epilepsy syndrome	0.000214	0.0108	CbGeAlD
Furosemide—SLC12A1—central nervous system—epilepsy syndrome	0.000212	0.0107	CbGeAlD
Furosemide—SLCO2A1—nervous system—epilepsy syndrome	0.000203	0.0103	CbGeAlD
Furosemide—CA12—head—epilepsy syndrome	0.000201	0.0102	CbGeAlD
Furosemide—CA4—telencephalon—epilepsy syndrome	0.0002	0.0101	CbGeAlD
Furosemide—SLCO2A1—central nervous system—epilepsy syndrome	0.000195	0.00988	CbGeAlD
Furosemide—CA12—nervous system—epilepsy syndrome	0.000191	0.00965	CbGeAlD
Furosemide—PGD—head—epilepsy syndrome	0.000191	0.00964	CbGeAlD
Furosemide—CA14—brain—epilepsy syndrome	0.000187	0.00946	CbGeAlD
Furosemide—CA2—brainstem—epilepsy syndrome	0.000187	0.00946	CbGeAlD
Furosemide—CA12—central nervous system—epilepsy syndrome	0.000184	0.0093	CbGeAlD
Furosemide—PGD—nervous system—epilepsy syndrome	0.000181	0.00914	CbGeAlD
Furosemide—CA5B—head—epilepsy syndrome	0.000181	0.00914	CbGeAlD
Furosemide—CA2—forebrain—epilepsy syndrome	0.00018	0.00913	CbGeAlD
Furosemide—CA1—spinal cord—epilepsy syndrome	0.000179	0.00908	CbGeAlD
Furosemide—PGD—central nervous system—epilepsy syndrome	0.000174	0.0088	CbGeAlD
Furosemide—CA5B—nervous system—epilepsy syndrome	0.000171	0.00866	CbGeAlD
Furosemide—PGD—cerebellum—epilepsy syndrome	0.00017	0.0086	CbGeAlD
Furosemide—SLC12A1—brain—epilepsy syndrome	0.000168	0.0085	CbGeAlD
Furosemide—CA2—telencephalon—epilepsy syndrome	0.000166	0.0084	CbGeAlD
Furosemide—CA5B—central nervous system—epilepsy syndrome	0.000165	0.00834	CbGeAlD
Furosemide—SLC22A6—brain—epilepsy syndrome	0.000163	0.00824	CbGeAlD
Furosemide—CA1—head—epilepsy syndrome	0.000159	0.00807	CbGeAlD
Furosemide—CA4—medulla oblongata—epilepsy syndrome	0.000157	0.00796	CbGeAlD
Furosemide—SLCO2A1—brain—epilepsy syndrome	0.000155	0.00784	CbGeAlD
Furosemide—CA1—nervous system—epilepsy syndrome	0.000151	0.00765	CbGeAlD
Furosemide—CA12—brain—epilepsy syndrome	0.000146	0.00738	CbGeAlD
Furosemide—CA1—central nervous system—epilepsy syndrome	0.000146	0.00736	CbGeAlD
Furosemide—CA4—midbrain—epilepsy syndrome	0.000144	0.00727	CbGeAlD
Furosemide—CA4—spinal cord—epilepsy syndrome	0.00014	0.00709	CbGeAlD
Furosemide—PGD—brain—epilepsy syndrome	0.000138	0.00699	CbGeAlD
Furosemide—SLC22A8—head—epilepsy syndrome	0.000135	0.00681	CbGeAlD
Furosemide—CA5B—brain—epilepsy syndrome	0.000131	0.00662	CbGeAlD
Furosemide—CA2—medulla oblongata—epilepsy syndrome	0.00013	0.0066	CbGeAlD
Furosemide—SLC22A5—medulla oblongata—epilepsy syndrome	0.000128	0.00649	CbGeAlD
Furosemide—SLC22A8—nervous system—epilepsy syndrome	0.000128	0.00645	CbGeAlD
Furosemide—CA4—head—epilepsy syndrome	0.000125	0.00631	CbGeAlD
Furosemide—SLC22A8—central nervous system—epilepsy syndrome	0.000123	0.00621	CbGeAlD
Furosemide—CA2—midbrain—epilepsy syndrome	0.000119	0.00603	CbGeAlD
Furosemide—CA4—nervous system—epilepsy syndrome	0.000118	0.00598	CbGeAlD
Furosemide—SLC22A5—midbrain—epilepsy syndrome	0.000117	0.00593	CbGeAlD
Furosemide—CA2—spinal cord—epilepsy syndrome	0.000116	0.00588	CbGeAlD
Furosemide—CA1—brain—epilepsy syndrome	0.000116	0.00585	CbGeAlD
Furosemide—SLC22A5—spinal cord—epilepsy syndrome	0.000114	0.00579	CbGeAlD
Furosemide—CA4—central nervous system—epilepsy syndrome	0.000114	0.00576	CbGeAlD
Furosemide—CA4—cerebellum—epilepsy syndrome	0.000111	0.00563	CbGeAlD
Furosemide—CA2—head—epilepsy syndrome	0.000103	0.00523	CbGeAlD
Furosemide—ALB—brain—epilepsy syndrome	0.000102	0.00514	CbGeAlD
Furosemide—CA2—nervous system—epilepsy syndrome	9.8e-05	0.00496	CbGeAlD
Furosemide—SLC22A8—brain—epilepsy syndrome	9.75e-05	0.00493	CbGeAlD
Furosemide—CA2—central nervous system—epilepsy syndrome	9.43e-05	0.00477	CbGeAlD
Furosemide—CA2—cerebellum—epilepsy syndrome	9.22e-05	0.00466	CbGeAlD
Furosemide—SLC22A5—cerebellum—epilepsy syndrome	9.07e-05	0.00459	CbGeAlD
Furosemide—CA4—brain—epilepsy syndrome	9.03e-05	0.00457	CbGeAlD
Furosemide—CA2—brain—epilepsy syndrome	7.49e-05	0.00379	CbGeAlD
Furosemide—SLC22A5—brain—epilepsy syndrome	7.37e-05	0.00373	CbGeAlD
Furosemide—Bumetanide—PTGS2—epilepsy syndrome	6.14e-05	0.0234	CrCbGaD
Furosemide—Agranulocytosis—Topiramate—epilepsy syndrome	2.81e-05	0.000288	CcSEcCtD
Furosemide—Dry mouth—Valproic Acid—epilepsy syndrome	2.81e-05	0.000288	CcSEcCtD
Furosemide—Agitation—Pregabalin—epilepsy syndrome	2.8e-05	0.000287	CcSEcCtD
Furosemide—Headache—Levetiracetam—epilepsy syndrome	2.8e-05	0.000287	CcSEcCtD
Furosemide—Erythema—Gabapentin—epilepsy syndrome	2.8e-05	0.000287	CcSEcCtD
Furosemide—Malnutrition—Gabapentin—epilepsy syndrome	2.8e-05	0.000287	CcSEcCtD
Furosemide—Hypersensitivity—Clonazepam—epilepsy syndrome	2.78e-05	0.000285	CcSEcCtD
Furosemide—Dizziness—Vigabatrin—epilepsy syndrome	2.78e-05	0.000285	CcSEcCtD
Furosemide—Confusional state—Valproic Acid—epilepsy syndrome	2.77e-05	0.000284	CcSEcCtD
Furosemide—Pruritus—Zonisamide—epilepsy syndrome	2.77e-05	0.000284	CcSEcCtD
Furosemide—Hypersensitivity—Phenytoin—epilepsy syndrome	2.77e-05	0.000284	CcSEcCtD
Furosemide—Flatulence—Gabapentin—epilepsy syndrome	2.75e-05	0.000282	CcSEcCtD
Furosemide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	2.75e-05	0.000282	CcSEcCtD
Furosemide—Urticaria—Lamotrigine—epilepsy syndrome	2.75e-05	0.000282	CcSEcCtD
Furosemide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.75e-05	0.000282	CcSEcCtD
Furosemide—Nausea—Propofol—epilepsy syndrome	2.75e-05	0.000282	CcSEcCtD
Furosemide—Vomiting—Fosphenytoin—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Diarrhoea—Felbamate—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Vertigo—Pregabalin—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Abdominal pain—Lamotrigine—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Body temperature increased—Lamotrigine—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Dysgeusia—Gabapentin—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Dizziness—Diazepam—epilepsy syndrome	2.74e-05	0.000281	CcSEcCtD
Furosemide—Leukopenia—Pregabalin—epilepsy syndrome	2.73e-05	0.00028	CcSEcCtD
Furosemide—Rash—Fosphenytoin—epilepsy syndrome	2.72e-05	0.000279	CcSEcCtD
Furosemide—Dermatitis—Fosphenytoin—epilepsy syndrome	2.72e-05	0.000279	CcSEcCtD
Furosemide—Asthenia—Clonazepam—epilepsy syndrome	2.71e-05	0.000278	CcSEcCtD
Furosemide—Headache—Fosphenytoin—epilepsy syndrome	2.7e-05	0.000277	CcSEcCtD
Furosemide—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.7e-05	0.000277	CcSEcCtD
Furosemide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.69e-05	0.000276	CcSEcCtD
Furosemide—Asthenia—Phenytoin—epilepsy syndrome	2.69e-05	0.000276	CcSEcCtD
Furosemide—Nausea—Midazolam—epilepsy syndrome	2.69e-05	0.000276	CcSEcCtD
Furosemide—Muscle spasms—Gabapentin—epilepsy syndrome	2.69e-05	0.000276	CcSEcCtD
Furosemide—Diarrhoea—Zonisamide—epilepsy syndrome	2.68e-05	0.000275	CcSEcCtD
Furosemide—Asthenia—Oxcarbazepine—epilepsy syndrome	2.68e-05	0.000275	CcSEcCtD
Furosemide—Pruritus—Clonazepam—epilepsy syndrome	2.67e-05	0.000274	CcSEcCtD
Furosemide—Vomiting—Vigabatrin—epilepsy syndrome	2.67e-05	0.000274	CcSEcCtD
Furosemide—Skin disorder—Valproic Acid—epilepsy syndrome	2.67e-05	0.000274	CcSEcCtD
Furosemide—Urinary tract disorder—Topiramate—epilepsy syndrome	2.67e-05	0.000274	CcSEcCtD
Furosemide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.66e-05	0.000273	CcSEcCtD
Furosemide—Pruritus—Phenytoin—epilepsy syndrome	2.66e-05	0.000272	CcSEcCtD
Furosemide—Nausea—Levetiracetam—epilepsy syndrome	2.65e-05	0.000272	CcSEcCtD
Furosemide—Rash—Vigabatrin—epilepsy syndrome	2.65e-05	0.000272	CcSEcCtD
Furosemide—Dizziness—Felbamate—epilepsy syndrome	2.65e-05	0.000272	CcSEcCtD
Furosemide—Dermatitis—Vigabatrin—epilepsy syndrome	2.65e-05	0.000272	CcSEcCtD
Furosemide—Urethral disorder—Topiramate—epilepsy syndrome	2.65e-05	0.000271	CcSEcCtD
Furosemide—Pruritus—Oxcarbazepine—epilepsy syndrome	2.64e-05	0.000271	CcSEcCtD
Furosemide—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.64e-05	0.000271	CcSEcCtD
Furosemide—Vision blurred—Gabapentin—epilepsy syndrome	2.63e-05	0.00027	CcSEcCtD
Furosemide—Headache—Vigabatrin—epilepsy syndrome	2.63e-05	0.00027	CcSEcCtD
Furosemide—Vomiting—Diazepam—epilepsy syndrome	2.63e-05	0.00027	CcSEcCtD
Furosemide—Anorexia—Valproic Acid—epilepsy syndrome	2.62e-05	0.000269	CcSEcCtD
Furosemide—Rash—Diazepam—epilepsy syndrome	2.61e-05	0.000268	CcSEcCtD
Furosemide—Dermatitis—Diazepam—epilepsy syndrome	2.61e-05	0.000267	CcSEcCtD
Furosemide—Visual impairment—Topiramate—epilepsy syndrome	2.6e-05	0.000267	CcSEcCtD
Furosemide—Dizziness—Zonisamide—epilepsy syndrome	2.59e-05	0.000266	CcSEcCtD
Furosemide—Headache—Diazepam—epilepsy syndrome	2.59e-05	0.000266	CcSEcCtD
Furosemide—Diarrhoea—Clonazepam—epilepsy syndrome	2.59e-05	0.000265	CcSEcCtD
Furosemide—Anaemia—Gabapentin—epilepsy syndrome	2.58e-05	0.000265	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.58e-05	0.000264	CcSEcCtD
Furosemide—Hypotension—Valproic Acid—epilepsy syndrome	2.57e-05	0.000264	CcSEcCtD
Furosemide—Asthenia—Carbamazepine—epilepsy syndrome	2.57e-05	0.000264	CcSEcCtD
Furosemide—Agitation—Gabapentin—epilepsy syndrome	2.57e-05	0.000263	CcSEcCtD
Furosemide—Diarrhoea—Phenytoin—epilepsy syndrome	2.57e-05	0.000263	CcSEcCtD
Furosemide—Nausea—Fosphenytoin—epilepsy syndrome	2.56e-05	0.000263	CcSEcCtD
Furosemide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.56e-05	0.000262	CcSEcCtD
Furosemide—Erythema multiforme—Topiramate—epilepsy syndrome	2.55e-05	0.000262	CcSEcCtD
Furosemide—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.55e-05	0.000262	CcSEcCtD
Furosemide—Vomiting—Felbamate—epilepsy syndrome	2.55e-05	0.000261	CcSEcCtD
Furosemide—Dry mouth—Pregabalin—epilepsy syndrome	2.54e-05	0.00026	CcSEcCtD
Furosemide—Pruritus—Carbamazepine—epilepsy syndrome	2.54e-05	0.00026	CcSEcCtD
Furosemide—Rash—Felbamate—epilepsy syndrome	2.53e-05	0.000259	CcSEcCtD
Furosemide—Eye disorder—Topiramate—epilepsy syndrome	2.52e-05	0.000259	CcSEcCtD
Furosemide—Dermatitis—Felbamate—epilepsy syndrome	2.52e-05	0.000259	CcSEcCtD
Furosemide—Tinnitus—Topiramate—epilepsy syndrome	2.52e-05	0.000258	CcSEcCtD
Furosemide—Vertigo—Gabapentin—epilepsy syndrome	2.51e-05	0.000257	CcSEcCtD
Furosemide—Headache—Felbamate—epilepsy syndrome	2.51e-05	0.000257	CcSEcCtD
Furosemide—Confusional state—Pregabalin—epilepsy syndrome	2.51e-05	0.000257	CcSEcCtD
Furosemide—Leukopenia—Gabapentin—epilepsy syndrome	2.5e-05	0.000257	CcSEcCtD
Furosemide—Dizziness—Clonazepam—epilepsy syndrome	2.5e-05	0.000256	CcSEcCtD
Furosemide—Nausea—Vigabatrin—epilepsy syndrome	2.5e-05	0.000256	CcSEcCtD
Furosemide—Vomiting—Zonisamide—epilepsy syndrome	2.49e-05	0.000256	CcSEcCtD
Furosemide—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.49e-05	0.000255	CcSEcCtD
Furosemide—Asthenia—Lamotrigine—epilepsy syndrome	2.48e-05	0.000255	CcSEcCtD
Furosemide—Dizziness—Phenytoin—epilepsy syndrome	2.48e-05	0.000254	CcSEcCtD
Furosemide—Rash—Zonisamide—epilepsy syndrome	2.47e-05	0.000253	CcSEcCtD
Furosemide—Paraesthesia—Valproic Acid—epilepsy syndrome	2.47e-05	0.000253	CcSEcCtD
Furosemide—Dermatitis—Zonisamide—epilepsy syndrome	2.47e-05	0.000253	CcSEcCtD
Furosemide—Dizziness—Oxcarbazepine—epilepsy syndrome	2.47e-05	0.000253	CcSEcCtD
Furosemide—Nausea—Diazepam—epilepsy syndrome	2.46e-05	0.000252	CcSEcCtD
Furosemide—Headache—Zonisamide—epilepsy syndrome	2.46e-05	0.000252	CcSEcCtD
Furosemide—Diarrhoea—Carbamazepine—epilepsy syndrome	2.45e-05	0.000251	CcSEcCtD
Furosemide—Angiopathy—Topiramate—epilepsy syndrome	2.45e-05	0.000251	CcSEcCtD
Furosemide—Pruritus—Lamotrigine—epilepsy syndrome	2.45e-05	0.000251	CcSEcCtD
Furosemide—Shock—Pregabalin—epilepsy syndrome	2.45e-05	0.000251	CcSEcCtD
Furosemide—Somnolence—Valproic Acid—epilepsy syndrome	2.45e-05	0.000251	CcSEcCtD
Furosemide—Immune system disorder—Topiramate—epilepsy syndrome	2.44e-05	0.00025	CcSEcCtD
Furosemide—Nervous system disorder—Pregabalin—epilepsy syndrome	2.44e-05	0.00025	CcSEcCtD
Furosemide—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.44e-05	0.00025	CcSEcCtD
Furosemide—Skin disorder—Pregabalin—epilepsy syndrome	2.42e-05	0.000248	CcSEcCtD
Furosemide—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.41e-05	0.000247	CcSEcCtD
Furosemide—Vomiting—Clonazepam—epilepsy syndrome	2.4e-05	0.000246	CcSEcCtD
Furosemide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.39e-05	0.000245	CcSEcCtD
Furosemide—Vomiting—Phenytoin—epilepsy syndrome	2.39e-05	0.000245	CcSEcCtD
Furosemide—Rash—Clonazepam—epilepsy syndrome	2.38e-05	0.000244	CcSEcCtD
Furosemide—Dermatitis—Clonazepam—epilepsy syndrome	2.38e-05	0.000244	CcSEcCtD
Furosemide—Nausea—Felbamate—epilepsy syndrome	2.38e-05	0.000244	CcSEcCtD
Furosemide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.38e-05	0.000244	CcSEcCtD
Furosemide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Fatigue—Valproic Acid—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Anorexia—Pregabalin—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Dizziness—Carbamazepine—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Headache—Clonazepam—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Rash—Phenytoin—epilepsy syndrome	2.37e-05	0.000243	CcSEcCtD
Furosemide—Dermatitis—Phenytoin—epilepsy syndrome	2.36e-05	0.000242	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.36e-05	0.000242	CcSEcCtD
Furosemide—Rash—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Pain—Valproic Acid—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Constipation—Valproic Acid—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Headache—Phenytoin—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Erythema—Topiramate—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Malnutrition—Topiramate—epilepsy syndrome	2.35e-05	0.000241	CcSEcCtD
Furosemide—Headache—Oxcarbazepine—epilepsy syndrome	2.34e-05	0.00024	CcSEcCtD
Furosemide—Nausea—Zonisamide—epilepsy syndrome	2.33e-05	0.000239	CcSEcCtD
Furosemide—Dry mouth—Gabapentin—epilepsy syndrome	2.33e-05	0.000239	CcSEcCtD
Furosemide—Hypotension—Pregabalin—epilepsy syndrome	2.32e-05	0.000238	CcSEcCtD
Furosemide—Flatulence—Topiramate—epilepsy syndrome	2.32e-05	0.000238	CcSEcCtD
Furosemide—Dysgeusia—Topiramate—epilepsy syndrome	2.3e-05	0.000236	CcSEcCtD
Furosemide—Confusional state—Gabapentin—epilepsy syndrome	2.3e-05	0.000236	CcSEcCtD
Furosemide—Dizziness—Lamotrigine—epilepsy syndrome	2.29e-05	0.000235	CcSEcCtD
Furosemide—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.28e-05	0.000234	CcSEcCtD
Furosemide—Vomiting—Carbamazepine—epilepsy syndrome	2.28e-05	0.000234	CcSEcCtD
Furosemide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.27e-05	0.000232	CcSEcCtD
Furosemide—Muscle spasms—Topiramate—epilepsy syndrome	2.26e-05	0.000232	CcSEcCtD
Furosemide—Rash—Carbamazepine—epilepsy syndrome	2.26e-05	0.000232	CcSEcCtD
Furosemide—Dermatitis—Carbamazepine—epilepsy syndrome	2.26e-05	0.000231	CcSEcCtD
Furosemide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.25e-05	0.000231	CcSEcCtD
Furosemide—Nausea—Clonazepam—epilepsy syndrome	2.24e-05	0.00023	CcSEcCtD
Furosemide—Headache—Carbamazepine—epilepsy syndrome	2.24e-05	0.00023	CcSEcCtD
Furosemide—Shock—Gabapentin—epilepsy syndrome	2.24e-05	0.00023	CcSEcCtD
Furosemide—Nervous system disorder—Gabapentin—epilepsy syndrome	2.24e-05	0.000229	CcSEcCtD
Furosemide—Paraesthesia—Pregabalin—epilepsy syndrome	2.23e-05	0.000229	CcSEcCtD
Furosemide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.23e-05	0.000229	CcSEcCtD
Furosemide—Nausea—Phenytoin—epilepsy syndrome	2.23e-05	0.000229	CcSEcCtD
Furosemide—Nausea—Oxcarbazepine—epilepsy syndrome	2.22e-05	0.000227	CcSEcCtD
Furosemide—Vision blurred—Topiramate—epilepsy syndrome	2.22e-05	0.000227	CcSEcCtD
Furosemide—Skin disorder—Gabapentin—epilepsy syndrome	2.22e-05	0.000227	CcSEcCtD
Furosemide—Somnolence—Pregabalin—epilepsy syndrome	2.21e-05	0.000227	CcSEcCtD
Furosemide—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.21e-05	0.000226	CcSEcCtD
Furosemide—Vomiting—Lamotrigine—epilepsy syndrome	2.2e-05	0.000226	CcSEcCtD
Furosemide—Urticaria—Valproic Acid—epilepsy syndrome	2.19e-05	0.000224	CcSEcCtD
Furosemide—Rash—Lamotrigine—epilepsy syndrome	2.18e-05	0.000224	CcSEcCtD
Furosemide—Dermatitis—Lamotrigine—epilepsy syndrome	2.18e-05	0.000224	CcSEcCtD
Furosemide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.18e-05	0.000223	CcSEcCtD
Furosemide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.18e-05	0.000223	CcSEcCtD
Furosemide—Anorexia—Gabapentin—epilepsy syndrome	2.17e-05	0.000223	CcSEcCtD
Furosemide—Anaemia—Topiramate—epilepsy syndrome	2.17e-05	0.000223	CcSEcCtD
Furosemide—Headache—Lamotrigine—epilepsy syndrome	2.17e-05	0.000222	CcSEcCtD
Furosemide—Decreased appetite—Pregabalin—epilepsy syndrome	2.16e-05	0.000222	CcSEcCtD
Furosemide—Agitation—Topiramate—epilepsy syndrome	2.16e-05	0.000222	CcSEcCtD
Furosemide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.15e-05	0.00022	CcSEcCtD
Furosemide—Fatigue—Pregabalin—epilepsy syndrome	2.15e-05	0.00022	CcSEcCtD
Furosemide—Hypotension—Gabapentin—epilepsy syndrome	2.13e-05	0.000219	CcSEcCtD
Furosemide—Nausea—Carbamazepine—epilepsy syndrome	2.13e-05	0.000218	CcSEcCtD
Furosemide—Constipation—Pregabalin—epilepsy syndrome	2.13e-05	0.000218	CcSEcCtD
Furosemide—Pain—Pregabalin—epilepsy syndrome	2.13e-05	0.000218	CcSEcCtD
Furosemide—Vertigo—Topiramate—epilepsy syndrome	2.11e-05	0.000217	CcSEcCtD
Furosemide—Leukopenia—Topiramate—epilepsy syndrome	2.11e-05	0.000216	CcSEcCtD
Furosemide—Nausea—Lamotrigine—epilepsy syndrome	2.06e-05	0.000211	CcSEcCtD
Furosemide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.05e-05	0.00021	CcSEcCtD
Furosemide—Paraesthesia—Gabapentin—epilepsy syndrome	2.05e-05	0.00021	CcSEcCtD
Furosemide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.03e-05	0.000209	CcSEcCtD
Furosemide—Somnolence—Gabapentin—epilepsy syndrome	2.03e-05	0.000208	CcSEcCtD
Furosemide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.03e-05	0.000208	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.99e-05	0.000204	CcSEcCtD
Furosemide—Decreased appetite—Gabapentin—epilepsy syndrome	1.98e-05	0.000203	CcSEcCtD
Furosemide—Urticaria—Pregabalin—epilepsy syndrome	1.98e-05	0.000203	CcSEcCtD
Furosemide—Asthenia—Valproic Acid—epilepsy syndrome	1.97e-05	0.000202	CcSEcCtD
Furosemide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.97e-05	0.000202	CcSEcCtD
Furosemide—Fatigue—Gabapentin—epilepsy syndrome	1.97e-05	0.000202	CcSEcCtD
Furosemide—Abdominal pain—Pregabalin—epilepsy syndrome	1.97e-05	0.000202	CcSEcCtD
Furosemide—Body temperature increased—Pregabalin—epilepsy syndrome	1.97e-05	0.000202	CcSEcCtD
Furosemide—Dry mouth—Topiramate—epilepsy syndrome	1.96e-05	0.000201	CcSEcCtD
Furosemide—Pain—Gabapentin—epilepsy syndrome	1.95e-05	0.0002	CcSEcCtD
Furosemide—Constipation—Gabapentin—epilepsy syndrome	1.95e-05	0.0002	CcSEcCtD
Furosemide—Pruritus—Valproic Acid—epilepsy syndrome	1.95e-05	0.0002	CcSEcCtD
Furosemide—Confusional state—Topiramate—epilepsy syndrome	1.94e-05	0.000198	CcSEcCtD
Furosemide—Shock—Topiramate—epilepsy syndrome	1.89e-05	0.000194	CcSEcCtD
Furosemide—Diarrhoea—Valproic Acid—epilepsy syndrome	1.88e-05	0.000193	CcSEcCtD
Furosemide—Nervous system disorder—Topiramate—epilepsy syndrome	1.88e-05	0.000193	CcSEcCtD
Furosemide—Feeling abnormal—Gabapentin—epilepsy syndrome	1.88e-05	0.000193	CcSEcCtD
Furosemide—Thrombocytopenia—Topiramate—epilepsy syndrome	1.88e-05	0.000193	CcSEcCtD
Furosemide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.87e-05	0.000191	CcSEcCtD
Furosemide—Skin disorder—Topiramate—epilepsy syndrome	1.86e-05	0.000191	CcSEcCtD
Furosemide—Hyperhidrosis—Topiramate—epilepsy syndrome	1.86e-05	0.00019	CcSEcCtD
Furosemide—Hypersensitivity—Pregabalin—epilepsy syndrome	1.83e-05	0.000188	CcSEcCtD
Furosemide—Anorexia—Topiramate—epilepsy syndrome	1.83e-05	0.000188	CcSEcCtD
Furosemide—Dizziness—Valproic Acid—epilepsy syndrome	1.82e-05	0.000187	CcSEcCtD
Furosemide—Urticaria—Gabapentin—epilepsy syndrome	1.81e-05	0.000186	CcSEcCtD
Furosemide—Abdominal pain—Gabapentin—epilepsy syndrome	1.8e-05	0.000185	CcSEcCtD
Furosemide—Body temperature increased—Gabapentin—epilepsy syndrome	1.8e-05	0.000185	CcSEcCtD
Furosemide—Hypotension—Topiramate—epilepsy syndrome	1.79e-05	0.000184	CcSEcCtD
Furosemide—Asthenia—Pregabalin—epilepsy syndrome	1.79e-05	0.000183	CcSEcCtD
Furosemide—Pruritus—Pregabalin—epilepsy syndrome	1.76e-05	0.00018	CcSEcCtD
Furosemide—Vomiting—Valproic Acid—epilepsy syndrome	1.75e-05	0.000179	CcSEcCtD
Furosemide—Rash—Valproic Acid—epilepsy syndrome	1.74e-05	0.000178	CcSEcCtD
Furosemide—Dermatitis—Valproic Acid—epilepsy syndrome	1.73e-05	0.000178	CcSEcCtD
Furosemide—Headache—Valproic Acid—epilepsy syndrome	1.72e-05	0.000177	CcSEcCtD
Furosemide—Paraesthesia—Topiramate—epilepsy syndrome	1.72e-05	0.000177	CcSEcCtD
Furosemide—Somnolence—Topiramate—epilepsy syndrome	1.71e-05	0.000175	CcSEcCtD
Furosemide—Diarrhoea—Pregabalin—epilepsy syndrome	1.7e-05	0.000175	CcSEcCtD
Furosemide—Hypersensitivity—Gabapentin—epilepsy syndrome	1.68e-05	0.000172	CcSEcCtD
Furosemide—Decreased appetite—Topiramate—epilepsy syndrome	1.67e-05	0.000171	CcSEcCtD
Furosemide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.66e-05	0.00017	CcSEcCtD
Furosemide—Fatigue—Topiramate—epilepsy syndrome	1.65e-05	0.00017	CcSEcCtD
Furosemide—Dizziness—Pregabalin—epilepsy syndrome	1.65e-05	0.000169	CcSEcCtD
Furosemide—Constipation—Topiramate—epilepsy syndrome	1.64e-05	0.000168	CcSEcCtD
Furosemide—Pain—Topiramate—epilepsy syndrome	1.64e-05	0.000168	CcSEcCtD
Furosemide—Asthenia—Gabapentin—epilepsy syndrome	1.64e-05	0.000168	CcSEcCtD
Furosemide—Nausea—Valproic Acid—epilepsy syndrome	1.63e-05	0.000168	CcSEcCtD
Furosemide—Pruritus—Gabapentin—epilepsy syndrome	1.61e-05	0.000165	CcSEcCtD
Furosemide—Vomiting—Pregabalin—epilepsy syndrome	1.58e-05	0.000162	CcSEcCtD
Furosemide—Feeling abnormal—Topiramate—epilepsy syndrome	1.58e-05	0.000162	CcSEcCtD
Furosemide—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.57e-05	0.000161	CcSEcCtD
Furosemide—Rash—Pregabalin—epilepsy syndrome	1.57e-05	0.000161	CcSEcCtD
Furosemide—Dermatitis—Pregabalin—epilepsy syndrome	1.57e-05	0.000161	CcSEcCtD
Furosemide—Diarrhoea—Gabapentin—epilepsy syndrome	1.56e-05	0.00016	CcSEcCtD
Furosemide—Headache—Pregabalin—epilepsy syndrome	1.56e-05	0.00016	CcSEcCtD
Furosemide—Urticaria—Topiramate—epilepsy syndrome	1.52e-05	0.000156	CcSEcCtD
Furosemide—Abdominal pain—Topiramate—epilepsy syndrome	1.52e-05	0.000156	CcSEcCtD
Furosemide—Body temperature increased—Topiramate—epilepsy syndrome	1.52e-05	0.000156	CcSEcCtD
Furosemide—Dizziness—Gabapentin—epilepsy syndrome	1.51e-05	0.000155	CcSEcCtD
Furosemide—Nausea—Pregabalin—epilepsy syndrome	1.48e-05	0.000152	CcSEcCtD
Furosemide—Vomiting—Gabapentin—epilepsy syndrome	1.45e-05	0.000149	CcSEcCtD
Furosemide—Rash—Gabapentin—epilepsy syndrome	1.44e-05	0.000147	CcSEcCtD
Furosemide—Dermatitis—Gabapentin—epilepsy syndrome	1.44e-05	0.000147	CcSEcCtD
Furosemide—Headache—Gabapentin—epilepsy syndrome	1.43e-05	0.000147	CcSEcCtD
Furosemide—Hypersensitivity—Topiramate—epilepsy syndrome	1.41e-05	0.000145	CcSEcCtD
Furosemide—Asthenia—Topiramate—epilepsy syndrome	1.38e-05	0.000141	CcSEcCtD
Furosemide—Pruritus—Topiramate—epilepsy syndrome	1.36e-05	0.000139	CcSEcCtD
Furosemide—Nausea—Gabapentin—epilepsy syndrome	1.36e-05	0.000139	CcSEcCtD
Furosemide—Diarrhoea—Topiramate—epilepsy syndrome	1.31e-05	0.000135	CcSEcCtD
Furosemide—Dizziness—Topiramate—epilepsy syndrome	1.27e-05	0.00013	CcSEcCtD
Furosemide—Vomiting—Topiramate—epilepsy syndrome	1.22e-05	0.000125	CcSEcCtD
Furosemide—Rash—Topiramate—epilepsy syndrome	1.21e-05	0.000124	CcSEcCtD
Furosemide—Dermatitis—Topiramate—epilepsy syndrome	1.21e-05	0.000124	CcSEcCtD
Furosemide—Headache—Topiramate—epilepsy syndrome	1.2e-05	0.000123	CcSEcCtD
Furosemide—Nausea—Topiramate—epilepsy syndrome	1.14e-05	0.000117	CcSEcCtD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.25e-06	8.74e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—HMOX1—epilepsy syndrome	5.23e-06	8.71e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—GPX1—epilepsy syndrome	5.2e-06	8.67e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCG2—epilepsy syndrome	5.18e-06	8.64e-05	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.17e-06	8.62e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAT—epilepsy syndrome	5.16e-06	8.6e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP2D6—epilepsy syndrome	5.15e-06	8.59e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	5.15e-06	8.58e-05	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	5.13e-06	8.55e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KCNMA1—epilepsy syndrome	5.13e-06	8.54e-05	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.13e-06	8.54e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ADRA2A—epilepsy syndrome	5.12e-06	8.53e-05	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	5.1e-06	8.5e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—epilepsy syndrome	5.09e-06	8.49e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.08e-06	8.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	5.07e-06	8.45e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A1—epilepsy syndrome	5.07e-06	8.45e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SLC8A1—epilepsy syndrome	5.06e-06	8.44e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP2C19—epilepsy syndrome	5.05e-06	8.42e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—GPX1—epilepsy syndrome	5.04e-06	8.39e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GPX1—epilepsy syndrome	5.04e-06	8.39e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—ABCB1—epilepsy syndrome	5.02e-06	8.36e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP11A1—epilepsy syndrome	5.02e-06	8.36e-05	CbGpPWpGaD
Furosemide—PGD—Disease—IL6ST—epilepsy syndrome	5.02e-06	8.36e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLCB1—epilepsy syndrome	5.01e-06	8.36e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—TH—epilepsy syndrome	5e-06	8.33e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.98e-06	8.3e-05	CbGpPWpGaD
Furosemide—PGD—Disease—NOS2—epilepsy syndrome	4.98e-06	8.29e-05	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.96e-06	8.27e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ADRA2A—epilepsy syndrome	4.91e-06	8.17e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—epilepsy syndrome	4.88e-06	8.14e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A1—epilepsy syndrome	4.86e-06	8.1e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AGT—epilepsy syndrome	4.85e-06	8.09e-05	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	4.83e-06	8.05e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLCB1—epilepsy syndrome	4.81e-06	8.01e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—TH—epilepsy syndrome	4.79e-06	7.98e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PDXK—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—L2HGDH—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLUD1—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADK—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CERS1—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—FAR1—epilepsy syndrome	4.77e-06	7.96e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—epilepsy syndrome	4.76e-06	7.93e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.75e-06	7.91e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AGT—epilepsy syndrome	4.73e-06	7.88e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AGT—epilepsy syndrome	4.73e-06	7.88e-05	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	4.69e-06	7.82e-05	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—epilepsy syndrome	4.69e-06	7.81e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.68e-06	7.8e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—GPX1—epilepsy syndrome	4.67e-06	7.78e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A1—epilepsy syndrome	4.66e-06	7.77e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—epilepsy syndrome	4.64e-06	7.72e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—epilepsy syndrome	4.64e-06	7.72e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLCB1—epilepsy syndrome	4.61e-06	7.68e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—TH—epilepsy syndrome	4.59e-06	7.65e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	4.58e-06	7.64e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AGT—epilepsy syndrome	4.56e-06	7.61e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.55e-06	7.59e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP2D6—epilepsy syndrome	4.53e-06	7.55e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—epilepsy syndrome	4.47e-06	7.45e-05	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	4.47e-06	7.45e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AGT—epilepsy syndrome	4.42e-06	7.36e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AGT—epilepsy syndrome	4.42e-06	7.36e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	4.4e-06	7.34e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.38e-06	7.3e-05	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	4.38e-06	7.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NHLRC1—epilepsy syndrome	4.37e-06	7.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PNPO—epilepsy syndrome	4.37e-06	7.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—EPM2A—epilepsy syndrome	4.37e-06	7.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GAMT—epilepsy syndrome	4.37e-06	7.28e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—epilepsy syndrome	4.33e-06	7.21e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—epilepsy syndrome	4.33e-06	7.21e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.32e-06	7.19e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ADRA2A—epilepsy syndrome	4.31e-06	7.19e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—epilepsy syndrome	4.29e-06	7.16e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.28e-06	7.13e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PPIA—epilepsy syndrome	4.25e-06	7.09e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.23e-06	7.05e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.23e-06	7.05e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.18e-06	6.97e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—HMOX1—epilepsy syndrome	4.17e-06	6.95e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.14e-06	6.91e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.14e-06	6.9e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAT—epilepsy syndrome	4.11e-06	6.86e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A1—epilepsy syndrome	4.1e-06	6.83e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AGT—epilepsy syndrome	4.09e-06	6.82e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—POMC—epilepsy syndrome	4.09e-06	6.81e-05	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.07e-06	6.79e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA4—epilepsy syndrome	4.06e-06	6.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—QDPR—epilepsy syndrome	4.06e-06	6.77e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	4.06e-06	6.76e-05	CbGpPWpGaD
Furosemide—PGD—Disease—FGF2—epilepsy syndrome	4.06e-06	6.76e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLCB1—epilepsy syndrome	4.05e-06	6.75e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—TH—epilepsy syndrome	4.04e-06	6.73e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.01e-06	6.69e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—epilepsy syndrome	4.01e-06	6.68e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—epilepsy syndrome	4e-06	6.67e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—HMOX1—epilepsy syndrome	4e-06	6.66e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—POMC—epilepsy syndrome	3.98e-06	6.64e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—POMC—epilepsy syndrome	3.98e-06	6.64e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAT—epilepsy syndrome	3.94e-06	6.57e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ATP2A2—epilepsy syndrome	3.88e-06	6.47e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—POMC—epilepsy syndrome	3.84e-06	6.4e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—epilepsy syndrome	3.84e-06	6.4e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—HMOX1—epilepsy syndrome	3.83e-06	6.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—COX3—epilepsy syndrome	3.82e-06	6.36e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAT—epilepsy syndrome	3.78e-06	6.3e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.77e-06	6.29e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGA2—epilepsy syndrome	3.77e-06	6.28e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—epilepsy syndrome	3.73e-06	6.21e-05	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	3.72e-06	6.21e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPX1—epilepsy syndrome	3.72e-06	6.2e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—POMC—epilepsy syndrome	3.72e-06	6.2e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—POMC—epilepsy syndrome	3.72e-06	6.2e-05	CbGpPWpGaD
Furosemide—PGD—Disease—MTOR—epilepsy syndrome	3.69e-06	6.15e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—epilepsy syndrome	3.68e-06	6.13e-05	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—epilepsy syndrome	3.66e-06	6.1e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	3.64e-06	6.06e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—epilepsy syndrome	3.63e-06	6.05e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—epilepsy syndrome	3.63e-06	6.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—KCNB1—epilepsy syndrome	3.62e-06	6.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CACNA2D2—epilepsy syndrome	3.62e-06	6.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PFKL—epilepsy syndrome	3.62e-06	6.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLCO1A2—epilepsy syndrome	3.62e-06	6.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC6A8—epilepsy syndrome	3.62e-06	6.03e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPX1—epilepsy syndrome	3.57e-06	5.95e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.54e-06	5.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.51e-06	5.86e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—epilepsy syndrome	3.5e-06	5.84e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.45e-06	5.75e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—epilepsy syndrome	3.44e-06	5.74e-05	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.43e-06	5.72e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—epilepsy syndrome	3.42e-06	5.7e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—epilepsy syndrome	3.39e-06	5.65e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—epilepsy syndrome	3.39e-06	5.65e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—epilepsy syndrome	3.37e-06	5.62e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.36e-06	5.6e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAT—epilepsy syndrome	3.32e-06	5.54e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ADRA2A—epilepsy syndrome	3.32e-06	5.53e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UPB1—epilepsy syndrome	3.31e-06	5.52e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NEU1—epilepsy syndrome	3.31e-06	5.52e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ATIC—epilepsy syndrome	3.31e-06	5.52e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAT—epilepsy syndrome	3.3e-06	5.5e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—epilepsy syndrome	3.26e-06	5.44e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—epilepsy syndrome	3.26e-06	5.43e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—epilepsy syndrome	3.23e-06	5.39e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—epilepsy syndrome	3.2e-06	5.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD17B4—epilepsy syndrome	3.19e-06	5.31e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—epilepsy syndrome	3.18e-06	5.29e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—epilepsy syndrome	3.18e-06	5.29e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—epilepsy syndrome	3.14e-06	5.23e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—epilepsy syndrome	3.13e-06	5.21e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS1—epilepsy syndrome	3.11e-06	5.18e-05	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.11e-06	5.17e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP1R3C—epilepsy syndrome	3.08e-06	5.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GBE1—epilepsy syndrome	3.08e-06	5.13e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—epilepsy syndrome	3.06e-06	5.11e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—epilepsy syndrome	3.06e-06	5.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.01e-06	5.01e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—epilepsy syndrome	3.01e-06	5.01e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—epilepsy syndrome	3e-06	5e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—epilepsy syndrome	2.97e-06	4.94e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—epilepsy syndrome	2.97e-06	4.94e-05	CbGpPWpGaD
Furosemide—PGD—Disease—SRC—epilepsy syndrome	2.96e-06	4.93e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—epilepsy syndrome	2.94e-06	4.9e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT3—epilepsy syndrome	2.91e-06	4.85e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ASAH1—epilepsy syndrome	2.89e-06	4.82e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAUR—epilepsy syndrome	2.87e-06	4.79e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.86e-06	4.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—STXBP1—epilepsy syndrome	2.81e-06	4.69e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—epilepsy syndrome	2.75e-06	4.58e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—epilepsy syndrome	2.75e-06	4.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NT5E—epilepsy syndrome	2.74e-06	4.57e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALAD—epilepsy syndrome	2.74e-06	4.57e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.73e-06	4.55e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CDC42—epilepsy syndrome	2.65e-06	4.42e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—epilepsy syndrome	2.64e-06	4.39e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—epilepsy syndrome	2.63e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDH7A1—epilepsy syndrome	2.62e-06	4.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CACNA1A—epilepsy syndrome	2.62e-06	4.36e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.59e-06	4.32e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—epilepsy syndrome	2.58e-06	4.31e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ST3GAL3—epilepsy syndrome	2.56e-06	4.27e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—epilepsy syndrome	2.52e-06	4.21e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.51e-06	4.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADSL—epilepsy syndrome	2.51e-06	4.18e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—epilepsy syndrome	2.5e-06	4.17e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLUL—epilepsy syndrome	2.46e-06	4.1e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CACNA1D—epilepsy syndrome	2.41e-06	4.02e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—epilepsy syndrome	2.4e-06	4e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FYN—epilepsy syndrome	2.36e-06	3.94e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—epilepsy syndrome	2.3e-06	3.84e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—YWHAZ—epilepsy syndrome	2.27e-06	3.78e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TXNRD1—epilepsy syndrome	2.26e-06	3.76e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.24e-06	3.74e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.22e-06	3.71e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—epilepsy syndrome	2.22e-06	3.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AQP1—epilepsy syndrome	2.19e-06	3.65e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—epilepsy syndrome	2.19e-06	3.65e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.15e-06	3.59e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2.14e-06	3.56e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.11e-06	3.51e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—epilepsy syndrome	2.1e-06	3.5e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	2.08e-06	3.47e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—epilepsy syndrome	2.02e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAU—epilepsy syndrome	2.02e-06	3.36e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—epilepsy syndrome	2.01e-06	3.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.98e-06	3.3e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CHRM3—epilepsy syndrome	1.98e-06	3.3e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.87e-06	3.12e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—epilepsy syndrome	1.85e-06	3.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.85e-06	3.08e-05	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—epilepsy syndrome	1.84e-06	3.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.81e-06	3.01e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	2.95e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—epilepsy syndrome	1.64e-06	2.73e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG2—epilepsy syndrome	1.62e-06	2.69e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—epilepsy syndrome	1.6e-06	2.66e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—epilepsy syndrome	1.6e-06	2.66e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.57e-06	2.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.57e-06	2.61e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.55e-06	2.59e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—epilepsy syndrome	1.54e-06	2.57e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—epilepsy syndrome	1.49e-06	2.48e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—epilepsy syndrome	1.49e-06	2.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.41e-06	2.35e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—epilepsy syndrome	1.38e-06	2.3e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.34e-06	2.24e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—epilepsy syndrome	1.34e-06	2.23e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.33e-06	2.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.28e-06	2.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCB1—epilepsy syndrome	1.26e-06	2.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TH—epilepsy syndrome	1.26e-06	2.1e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.24e-06	2.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SRC—epilepsy syndrome	1.1e-06	1.84e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—epilepsy syndrome	1.1e-06	1.83e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.07e-06	1.79e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—epilepsy syndrome	1.06e-06	1.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—epilepsy syndrome	1.05e-06	1.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAT—epilepsy syndrome	1.04e-06	1.73e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—epilepsy syndrome	1.01e-06	1.68e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—epilepsy syndrome	9.38e-07	1.56e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—epilepsy syndrome	8.9e-07	1.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—epilepsy syndrome	8.22e-07	1.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—epilepsy syndrome	8.06e-07	1.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—epilepsy syndrome	6.92e-07	1.15e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—epilepsy syndrome	6.84e-07	1.14e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—epilepsy syndrome	5.52e-07	9.2e-06	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—epilepsy syndrome	2.77e-07	4.62e-06	CbGpPWpGaD
